Blog
RSS FeedPosted by Michael Wonder on 08 Mar 2021
Pacific pharmacists want inclusion on PHARMAC review
6 March 2021 - The President of the Pacific Pharmacists’Association, Kasey Brown, says a review of New Zealand’s drug buying ...
Posted by Michael Wonder on 07 Mar 2021
Cancer Society says PHARMAC review doesn't go far enough
3 March 2021 - A review of drug buying agency PHARMAC is being described as long overdue. ...
Posted by Michael Wonder on 04 Mar 2021
The PHARMAC non-review?
4 March 2021 - The recently announced PHARMAC review is fatally flawed. ...
Posted by Michael Wonder on 03 Mar 2021
PHARMAC ripe for reassessment
3 March 2021 - New Zealand’s drug buying agency PHARMAC has long been, simultaneously, a good thing in itself and ...
Posted by Michael Wonder on 02 Mar 2021
Government announces review into PHARMAC
2 March 2021 - The Government is following through on an election promise to conduct an independent review into PHARMAC, ...
Posted by Michael Wonder on 02 Mar 2021
Medicines New Zealand supportive of Government’s PHARMAC review assuming it is not a box-ticking exercise
2 March 2021 - Medicines New Zealand is supportive of the proposed review into PHARMAC if it is intended to improve ...
Posted by Michael Wonder on 01 Mar 2021
Review asks how Government can get the new drugs it wants funded
2 March 2021 - The much-vaunted PHARMAC inquiry, being announced today, will investigate how the drug-buying agency can be brought ...
Posted by Michael Wonder on 21 Feb 2021
Epilepsy drug deaths: Coronial inquiry into medication-linked deaths resumes
22 February 2021 - A coronial inquiry into the deaths of six patients whose epilepsy medication was changed before they ...
Posted by Michael Wonder on 17 Feb 2021
TLV is tasked with reducing costs for medicines
16 February 2021 - The Government has commissioned the Swedish Dental and Pharmaceutical Benefits Agency, TLV, to implement measures to reduce ...
Posted by Michael Wonder on 07 Feb 2021
Modifying NICE’s approach to equity weighting
7 February 2021 - The UK’s NICE recently launched a consultation on the methods it uses to evaluate new health technologies, ...
Posted by Michael Wonder on 07 Feb 2021
NICE’s discounting review: clear thinking on rational revision meets obstacle of industrial interests
7 February 2021 - NICE recently published a review of discounting practice and theory as part of a consultation on ...
Posted by Michael Wonder on 04 Feb 2021
NICE’s processes of technology evaluation - presenting a case for change
4 February 2021 - NICE has today launched a public consultation on proposals for changes to the processes it uses to ...
Posted by Michael Wonder on 18 Jan 2021
FDA sped progress for most of 2020's novel drugs
14 January 2021 - Most novel drugs approved by the US FDA in 2020 made their way through the approvals process ...
Posted by Michael Wonder on 07 Dec 2020
Jacinda Ardern defends Labour's 'perfectly reasonable' decision to veto MP led PHARMAC inquiry
7 December 2020 - Prime Minister Jacinda Ardern is defending Labour's "perfectly reasonable" decision to veto a PHARMAC inquiry led ...
Posted by Michael Wonder on 06 Dec 2020
Government promises independent PHARMAC review after Labour MPs veto Health Select Committee inquiry
3 December 2020 - National MPs have lashed out at Labour for voting against a politician-led inquiry into PHARMAC but ...